Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Abbott Laboratories (rights to Gabitril)

Abbott Laboratories (rights to Gabitril)
1998 FOUNDED
M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A drug manufacturing rights. The drug is a treatment for partial seizures related to epilepsy enabling patience in reducing the frequency of partial seizures when added to an existing regimen of at least one other antiepilepsy drug.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Primary Office
  • Chicago, IL
  • United States

Abbott Laboratories (rights to Gabitril) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Abbott Laboratories (rights to Gabitril)‘s full profile, request access.

Request full access to PitchBook

Abbott Laboratories (rights to Gabitril) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Abbott Laboratories (rights to Gabitril)‘s full profile, request access.

Request full access to PitchBook